Fate Therapeutics Inc.
FATE | NASDAQ
$2.60
+$0.07 (+2.77%)
Sep 22, 2026, 1:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -30.16M | -31.21M | -32.37M | -32.25M | -34.07M | -37.62M | -52.15M | -47.68M | -38.43M | -48M | -44.12M | -45.17M | -52.76M | -18.88M | -56.36M | -83.56M | -76.11M | -65.69M | -68.62M | -43.31M | -55.13M | -45.09M |
Depreciation & Amortization | 2.78M | 2.15M | 3.06M | 3.23M | 3.28M | 3.33M | 4.81M | 4.61M | 4.72M | 4.82M | 4.89M | 4.74M | 4.47M | 4.19M | 4.84M | 3.19M | 2.96M | 2.76M | 2.21M | 1.52M | 1.17M | 959K |
Stock-Based Compensation | 3.52M | 3.93M | 5.53M | 4.86M | 7.15M | 7.38M | 9.12M | 11.77M | 9.63M | 10.98M | n/a | 10.1M | n/a | 10.98M | n/a | 19.47M | 20.54M | 19.33M | 14.59M | 13.54M | 13.25M | 12.98M |
Other Working Capital | -1.32M | -402K | 1.29M | -209K | -937K | -6.51M | -2.5M | 3.74M | -3.6M | -354K | 1.99M | -4.12M | 3.75M | 7.57M | -7.68M | -3.06M | -1.89M | -2.46M | -11.5M | 6.28M | 2.9M | 7.58M |
Other Non-Cash Items | 491K | 280K | -586K | -716K | -1.02M | -1.53M | 12.33M | -1.24M | -4.44M | -1.76M | 2.79M | -5.13M | 9.76M | -37.31M | 8.68M | -4.27M | 603K | -9.89M | -5.61M | -14.4M | 9.07M | -2.09M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -64K | -5.96M | 1.06M | 504K | 73K | -5.37M | -1.91M | 3.13M | -3.79M | 614K | -189K | -2.82M | 10.04M | 12.15M | -32.55M | 10.12M | -1.16M | -11.13M | -12.87M | 9.28M | -460K | 6.15M |
Operating Cash Flow | -23.43M | -30.82M | -23.31M | -24.37M | -24.59M | -33.81M | -27.8M | -29.42M | -32.31M | -33.35M | -36.64M | -38.27M | -28.49M | -28.86M | -75.39M | -55.05M | -53.16M | -64.61M | -70.29M | -33.38M | -32.11M | -27.1M |
Capital Expenditures | -80K | -239K | -1.19M | -2.2M | -1.36M | -1.2M | -98K | -495K | -51K | -86K | -181K | -565K | -2.2M | -3.21M | -6.68M | -8.68M | -10.13M | -10.08M | -18.37M | -14.74M | -13.62M | -3.98M |
Cash Acquisitions | n/a | n/a | -122K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -58.35M | -28.73M | -37.73M | -57.98M | -50.81M | -48.62M | -38.01M | -64.74M | -128.67M | -86.34M | -49.97M | -102.13M | -92.26M | -114.45M | -107.1M | -101.58M | -63.95M | -132.17M | -173.45M | -165.47M | -99.34M | -529.91M |
Sales Maturities Of Investments | 72.98M | 52.56M | 66.32M | 81.45M | 71.64M | 92.49M | 60.92M | 90.7M | 75.34M | 103.74M | 95.5M | 127.5M | 127.63M | 127M | 166.89M | 190.63M | 114.37M | 135.22M | 263.09M | 258.16M | 111.58M | 62M |
Other Investing Acitivies | n/a | n/a | 359K | 3K | 122K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 14.56M | 23.59M | 27.63M | 21.27M | 19.59M | 42.67M | 22.82M | 25.46M | -53.37M | 17.31M | 45.35M | 24.81M | 33.17M | 9.34M | 53.11M | 80.38M | 40.29M | -7.03M | 71.28M | 77.96M | -1.37M | -471.89M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.32M | n/a | 1.69M | 2.48M | 1.33M | n/a | 3.13M | n/a | 1.94M | 20.3M | n/a | n/a | n/a | n/a | n/a | n/a | 3.41M | n/a | 3.45M | 28.62M | 3.72M | 5.61M |
Financial Cash Flow | 1.74M | n/a | 1.69M | 2.48M | 1.33M | n/a | 3.13M | n/a | 1.27M | 95.49M | -180K | n/a | 58K | 207K | 1.52M | 1.49M | 3.41M | 2.8M | 3.42M | 7.94M | 3.72M | 438.05M |
Net Cash Flow | -7.14M | -7.24M | 6.01M | -627K | -3.67M | 8.86M | -1.85M | 992K | -84.41M | 79.45M | 8.54M | -13.47M | 4.78M | -19.31M | -20.76M | 26.82M | -9.47M | -68.84M | 4.4M | 52.53M | -29.76M | -60.93M |
Free Cash Flow | -23.51M | -31.06M | -24.51M | -26.58M | -25.95M | -35.01M | -27.9M | -29.91M | -32.36M | -33.44M | -36.82M | -38.84M | -30.69M | -32.07M | -82.07M | -63.72M | -63.29M | -74.7M | -88.66M | -48.11M | -45.73M | -31.08M |
Adj. Free Cash Flow | -27.03M | -34.99M | -30.03M | -31.44M | -33.1M | -42.39M | -37.02M | -41.68M | -41.99M | -44.42M | -36.82M | -48.94M | -30.69M | -43.05M | -82.07M | -83.19M | -83.83M | -94.03M | -103.26M | -61.65M | -58.98M | -44.05M |
Maintenance CapEx | -80K | -239K | -1.19M | -2.2M | -1.36M | -1.2M | n/a | n/a | n/a | -86K | -181K | -565K | -2.2M | n/a | n/a | -7.37M | -1.22M | n/a | -15.32M | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -98K | -495K | -51K | n/a | n/a | n/a | n/a | -3.21M | -6.68M | -1.31M | -8.9M | -10.08M | -3.05M | -14.74M | -13.62M | -3.98M |
Owner Earnings | -23.51M | -31.06M | -24.51M | -26.58M | -25.95M | -35.01M | -27.8M | -29.42M | -32.31M | -33.44M | -36.82M | -38.84M | -30.69M | -28.86M | -75.39M | -62.41M | -54.38M | -64.61M | -85.61M | -33.38M | -32.11M | -27.1M |
Add to Watchlist
Select watchlists to add or remove FATE